<!DOCTYPE html><html><head><title>Osteoporosis: percentage of women age 50 to 85 who suffered a fracture and who either had a bone mineral density test or received a prescription for a drug to treat osteoporosis.</title><link rel="stylesheet" type="text/css" href="style.css"></head><body><div class='section'>
<h2>General
</h2>
<div class='field field_text'>
<h3>
Title
</h3>
<div class='FieldValue'>
<div class="content_title">Osteoporosis: percentage of women age 50 to 85 who suffered a fracture and who either had a bone mineral density test or received a prescription for a drug to treat osteoporosis.</div>
</div>

</div>
<div class='field field_citation'>
<h3>
Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>National Committee for Quality Assurance (NCQA). Osteoporosis: osteoporosis management in women who had a fracture. Washington (DC): National Committee for Quality Assurance (NCQA); 2015 Jun 5. 3 p. </td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>Measure Domain
</h2>
<div class='field field_picklist-one'>
<h3>
Primary Measure Domain
</h3>
<div class='FieldValue'>
Clinical Quality Measures: Process
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Secondary Measure Domain
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>

</div>
<div class='section'>
<h2>Brief Abstract
</h2>
<div class='field field_text'>
<h3>
Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure is used to assess the percentage of women age 50 to 85 who suffered a fracture and who either had a bone mineral density test or received a prescription for a drug to treat osteoporosis.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Rationale
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The intent of this measure is secondary prevention of fractures through the appropriate diagnosis and treatment of osteoporosis. Detecting osteoporosis and initiating treatment will help to prevent future fractures from occurring. Future fractures, especially in the older population, can cause significant health issues, decline in function, and, in some cases lead to mortality.</p>
<p><strong>The following clinical recommendation statements are quoted <span style="text-decoration: underline;">verbatim</span> from the referenced clinical guidelines and represent the evidence base for the measure</strong>: </p>
<p>Appropriate follow-up care for a fracture in post-menopausal women includes either 1) bone mineral density testing to assess whether a patient has osteoporosis or 2) receiving pharmacologic therapy to treat osteoporosis. This measure is based on guidelines and evidence that patients at high risk of fracture, including a patients with a history of fragility fractures, should be screened for osteoporosis (U.S. Preventive Services Task Force [USPSTF], 2012; Nelson et al., 2010; Watts et al., 2010) and that patients who have a fragility fracture of the hip or spine should be provided with a treatment for osteoporosis (Watts et al., 2010; Crandall et al., 2012). </p>
<p>"The USPSTF recommends screening for osteoporosis in women aged 65 years or older and in younger women whose fracture risk is equal to or greater than that of a 65-year-old white woman who has no additional risk factors" (USPSTF, 2011). </p>
<p>All postmenopausal women with a history of fracture without major trauma should receive a bone mineral density test to test for osteoporosis (Watts et al., 2010). Patients who have a history of fracture of the hip or spine also need pharmacologic therapy to treat for osteoporosis (Watts et al., 2010; Cosman et al., 2014). </p></div>
</div>

</div>
<div class='field field_citation'>
<h3>
Evidence for Rationale
</h3>
<div class='FieldValue'>
<table><tr><td>Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014 Oct;25(10):2359-81. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=25182228" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Crandall CJ, Newberry SJ, Gellad WG, Diamant A, Lim YM, Suttorp M, Motala A, Ewing B, Roth B, Timmer M, Shanman R, Shekelle PG. Treatment to prevent fractures in men and women with low bone density or osteoporosis: update of a 2007 report (Prepared by Southern California Evidence based Practice Center under Contract No. HHSA-290-2007-10062-I.). Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2012 Mar. 438 p.&nbsp;(Comparative effectiveness review; no. 53).&nbsp;</td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>National Committee for Quality Assurance (NCQA). Osteoporosis: osteoporosis management in women who had a fracture. Washington (DC): National Committee for Quality Assurance (NCQA); 2015 Jun 5. 3 p. </td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Nelson HD, Haney EM, Chou R, Dana T, Fu R, Bougatsos C. Screening for osteoporosis. Systematic review to update the 2002 U.S. Preventive Services Task Force Recommendation. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2010 Jul. </td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>U.S. Preventive Services Task Force (USPSTF). Final update summary: osteoporosis: screening. [internet]. Rockville (MD): U.S. Preventive Services Task Force (USPSTF); 2011 Jan&nbsp;[accessed 2015 Jul 01]. </td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, Kleerekoper M, Luckey MM, McClung MR, Pollack RP, Petak SM, AACE Osteoporosis Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract. 2010 Nov-Dec;16(Suppl 3):1-37. [209 references] <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=21224201" target="_blank">PubMed</a></td></tr></table>
</div>

</div>
<div class='field field_text'>
<h3>
Primary Health Components
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Osteoporosis; fracture; bone mineral density test; pharmacologic therapy</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Denominator Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Women who experienced a fracture, except fractures of the finger, toe, face or skull (see the related "Denominator Inclusions/Exclusions" field)</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Numerator Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Patients who received either a bone mineral density test or a prescription for a drug to treat osteoporosis after a fracture occurs (see the related "Numerator Inclusions/Exclusions" field)</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Evidence Supporting the Measure
</h2>
<div class='field field_picklist-choice'>
<h3>
Type of Evidence Supporting the Criterion of Quality for the Measure
</h3>
<div class='FieldValue'>
A clinical practice guideline or other peer-reviewed synthesis of the clinical research evidence
</div>
<div class='FieldValue'>
One or more research studies published in a National Library of Medicine (NLM) indexed, peer-reviewed journal
</div>

</div>
<div class='field field_text'>
<h3>
Additional Information Supporting Need for the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Extent of Measure Testing
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>State of Use of the Measure
</h2>
<div class='field field_picklist-one'>
<h3>
State of Use
</h3>
<div class='FieldValue'>
Current routine use
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Current Use
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>

</div>
<div class='section'>
<h2>Application of the Measure in its Current Use
</h2>
<div class='field field_picklist-choice'>
<h3>
Measurement Setting
</h3>
<div class='FieldValue'>
Ambulatory/Office-based Care
</div>
<div class='FieldValue'>
Ambulatory Procedure/Imaging Center
</div>
<div class='FieldValue'>
Hospital Outpatient
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Professionals Involved in Delivery of Health Services
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Least Aggregated Level of Services Delivery Addressed
</h3>
<div class='FieldValue'>
Individual Clinicians or Public Health Professionals
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Statement of Acceptable Minimum Sample Size
</h3>
<div class='FieldValue'>
Unspecified
</div>

</div>
<div class='field field_text'>
<h3>
Target Population Age
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Age 50 to 85 years</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Target Population Gender
</h3>
<div class='FieldValue'>
Female (only)
</div>

</div>

</div>
<div class='section'>
<h2>National Strategy for Quality Improvement in Health Care
</h2>
<div class='field field_text'>
<h3>
National Quality Strategy Aim
</h3>
<div class='FieldValue'>
<ul><li>Better Care</li></ul>
</div>

</div>
<div class='field field_text'>
<h3>
National Quality Strategy Priority
</h3>
<div class='FieldValue'>
<ul><li>Prevention and Treatment of Leading Causes of Mortality</li></ul>
</div>

</div>

</div>
<div class='section'>
<h2>Institute of Medicine (IOM) National Health Care Quality Report Categories
</h2>
<div class='field field_picklist-choice'>
<h3>
IOM Care Need
</h3>
<div class='FieldValue'>
Getting Better
</div>
<div class='FieldValue'>
Living with Illness
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
IOM Domain
</h3>
<div class='FieldValue'>
Effectiveness
</div>

</div>

</div>
<div class='section'>
<h2>Data Collection for the Measure
</h2>
<div class='field field_text'>
<h3>
Case Finding Period
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The reporting period</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Denominator Sampling Frame
</h3>
<div class='FieldValue'>
Patients associated with provider
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Denominator (Index) Event or Characteristic
</h3>
<div class='FieldValue'>
Clinical Condition
</div>
<div class='FieldValue'>
Encounter
</div>
<div class='FieldValue'>
Patient/Individual (Consumer) Characteristic
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Denominator Time Window
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Denominator Inclusions/Exclusions
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Inclusions</strong><br />
Women who experienced a fracture, except fractures of the finger, toe, face or skull</p>
<p class="Note"><strong>Note</strong>: Refer to the original measure documentation for administrative codes.</p>
<p><strong>Exclusions</strong><br />
Unspecified</p>
<p><strong>Exceptions</strong></p>
<ul style="list-style-type: disc;">
    <li>Documentation of medical reason(s) for not performing a central dual energy X-ray absorptiometry (DXA) measurement (e.g., had a DXA in the past two years, received osteoporosis medication or therapy in the past 12 months) </li>
    <li>Documentation of patient reason(s) for not ordering or performing a central DXA measurement or not prescribing pharmacologic therapy for osteoporosis </li>
    <li>Documentation of system reason(s) for not ordering or performing a central DXA measurement or not prescribing pharmacologic therapy for osteoporosis </li>
</ul></div>
</div>

</div>
<div class='field field_picklist-choice-4'>
<h3>
Exclusions/Exceptions
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Numerator Inclusions/Exclusions
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Inclusions</strong> <br />
Patients who received either a bone mineral density test or a prescription for a drug to treat osteoporosis after a fracture occurs</p>
<p class="Note"><strong>Note</strong>:</p>
<ul class="Note" style="list-style-type: disc;">
    <li><strong>Pharmacologic Therapy</strong>: U.S. Food and Drug Administration approved pharmacologic options for osteoporosis prevention and/or treatment of postmenopausal osteoporosis include, in alphabetical order: bisphosphonates (alendronate, alendronate-cholecalciferol, calcium carbonate-risedronate, ibandronate, risedronate, zoledronic acid, calcitonin, teriparatide, denosumab, and raloxifene. </li>
    <li><strong>Prescribed</strong>: May include prescription given to the patient for treatment of osteoporosis (as listed above) at one or more encounters during the reporting period, or documentation that patient is already taking pharmacologic therapy for osteoporosis, as documented in the current medical list. </li>
    <li>Refer to the original measure documentation for administrative codes. </li>
</ul>
<p><strong>Exclusions</strong><br />
Unspecified</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Numerator Search Strategy
</h3>
<div class='FieldValue'>
Fixed time period or point in time
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Data Source
</h3>
<div class='FieldValue'>
Administrative clinical data
</div>
<div class='FieldValue'>
Electronic health/medical record
</div>
<div class='FieldValue'>
Paper medical record
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Type of Health State
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>
<div class='field field_text'>
<h3>
Instruments Used and/or Associated with the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Computation of the Measure
</h2>
<div class='field field_picklist-one'>
<h3>
Measure Specifies Disaggregation
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Scoring
</h3>
<div class='FieldValue'>
Rate/Proportion
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Interpretation of Score
</h3>
<div class='FieldValue'>
Desired value is a higher score
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Allowance for Patient or Population Factors
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Standard of Comparison
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>

</div>
<div class='section'>
<h2>Identifying Information
</h2>
<div class='field field_text'>
<h3>
Original Title
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Measure #40: osteoporosis management in women who had a fracture.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Collection Name
</h3>
<div class='FieldValue'>
Osteoporosis
</div>

</div>
<div class='field field_orglist'>
<h3>
Submitter
</h3>
<div class='FieldValue'>
National Committee for Quality Assurance - Health Care Accreditation Organization
</div>

</div>
<div class='field field_orglist-p'>
<h3>
Developer
</h3>
<div class='FieldValue'>
National Committee for Quality Assurance - Health Care Accreditation Organization
</div>

</div>
<div class='field field_text'>
<h3>
Funding Source(s)
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Composition of the Group that Developed the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p><em>Osteoporosis Work Group</em>: Steven Petak, MD, JD, FACE (<em>Co-chair</em>); Kenneth Saag, MD, MSc (<em>Co-chair</em>); Robert Adler, MD; C. Conrad Johnston, Jr., MD; H. Chris Alexander, III, MD, FACP; Joseph Lane, MD; Donald Bachman, MD, FACR; Leon Lenchik, MD; Joel Brill, MD; Bonnie McCafferty, MD, MSPH; Jan Busby-Whitehead, MD; Michael Maricic, MD; Thomas Dent, MD; Michael L. O'Dell, MD, MSHA, FAAFP; Nancy Dolan, MD; Sam J. W. Romeo, MD, MBA; Leonie Gordon, MB, ChB; Frank Salvi, MD, MS; Tomas Griebling, MD; Joseph Shaker, MD; Richard Hellman, MD, FACP, FACE; Madhavi Vemireddy, MD; Marc C. Hochberg, MD, MPH; David Wong, MD, MSc, FRS(C)</p>
<p><em>American Academy of Family Physicians</em>: Bruce Bagley, MD; Janet Leiker, RN, MPH, CPHQ</p>
<p><em>American Academy of Orthopaedic Surgeons</em>: Bob Haralson, MD, MBA; Jill Hughes</p>
<p><em>American Association of Clinical Endocrinologists</em>: Tammy L. Chaney</p>
<p><em>American College of Rheumatology</em>: Amy Miller</p>
<p><em>The Endocrine Society</em>: Janet Kreizman</p>
<p><em>Facilitators</em>: Timothy F. Kresowik, MD; Rebecca A. Kresowik</p>
<p><em>American Medical Association</em>: Karen S. Kmetik, PhD; Heidi Bossley, MSN, MBA</p>
<p><em>National Osteoporosis Foundation</em>: Roberta Biegel</p>
<p><em>National Committee for Quality Assurance</em>: Sarah Sampsel, MPH</p>
<p><em>The Joint Commission</em>: Ann Watt, RN</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Financial Disclosures/Other Potential Conflicts of Interest
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_orglist'>
<h3>
Endorser
</h3>
<div class='FieldValue'>
National Quality Forum - None
</div>

</div>
<div class='field field_plain-text'>
<h3>
NQF Number
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Date of Endorsement
</h3>
<div class='FieldValue'>
<div class="content_para"><p>201 Dec 30</p></div>
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Measure Initiative(s)
</h3>
<div class='FieldValue'>
Physician Quality Reporting System
</div>

</div>
<div class='field field_text'>
<h3>
Adaptation
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure was not adapted from another source.</p></div>
</div>

</div>
<div class='field field_date'>
<h3>
Date of Most Current Version in NQMC
</h3>
<div class='FieldValue'>
2015 Jun
</div>

</div>
<div class='field field_text'>
<h3>
Measure Maintenance
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Date of Next Anticipated Revision
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This is the current release of the measure. </p>
<p>This measure updates a previous version: American Academy of Family Physicians, American Academy of Orthopaedic Surgeons, American Association of Clinical Endocrinologists, American College of Rheumatology, The Endocrine Society, Physician Consortium for Performance Improvement&reg;, National Committee for Quality Assurance. Osteoporosis physician performance measurement set. Chicago (IL): American Medical Association (AMA); 2009 Nov. 18 p.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Availability
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Source not available electronically. </p>
<p>For more information, contact the National Committee for Quality Assurance (NCQA) at 1100 13th Street, NW, Suite 1000, Washington, DC 20005; Phone: 202-955-3500; Fax: 202-955-3599; Web site: <a href="http://www.ncqa.org/" title="NCQA Web site">www.ncqa.org</a>.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
NQMC Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This NQMC summary was completed by ECRI Institute on October 12, 2007. The information was verified by the measure developer on November 21, 2007. </p>
<p>This NQMC summary was retrofitted into the new template on June 8, 2011. </p>
<p>This NQMC summary was edited by ECRI Institute on April 27, 2012. </p>
<p>Stewardship for this measure was transferred from the PCPI to the NCQA. NCQA informed NQMC that this measure was updated. This NQMC summary was updated by ECRI Institute on September 21, 2015. The information was verified by the measure developer on November 3, 2015.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Copyright Statement
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This NQMC summary is based on the original measure, which is subject to the measure developer's copyright restrictions.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Production
</h2>
<div class='field field_citation'>
<h3>
Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>National Committee for Quality Assurance (NCQA). Osteoporosis: osteoporosis management in women who had a fracture. Washington (DC): National Committee for Quality Assurance (NCQA); 2015 Jun 5. 3 p. </td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>Disclaimer
</h2>
<div class='field field_text'>
<h3>
NQMC Disclaimer
</h3>
<div class='FieldValue'>
<p>The National Quality Measures Clearinghouse™ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.</p> 
<p>All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.</p> 
<p>Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the <a href="/help-and-about/summaries/inclusion-criteria">NQMC Inclusion Criteria</a>.</p> 
<p>NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding measure content are directed to contact the measure developer.</p>
</div>

</div>

</div>
</body></html>